vinblastine,Dacarbazine,nivolumab,doxorubicin
bms
['cml']
a moskowitz.
n-avd for older chl pts. g-csf mandatory. med age 66. relatively fit population.
cr 97%
pfs 86%, os 96% at 2 years.
very promising for the older!
#17icml 
Oncologist at Uppsala university hospital. Chair of the Swedish lymphoma group (SLG) and the Swedish Hodgkin lymphoma group.